The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians

被引:26
|
作者
Jones, Jennifer [1 ,2 ]
Bhatt, Jaimin [3 ,4 ,5 ]
Avery, Jonathan [6 ]
Laupacis, Andreas [7 ]
Cowan, Katherine [8 ]
Basappa, Naveen [9 ]
Basiuk, Joan [10 ]
Canil, Christina [11 ]
Al-Asaaed, Sohaib [12 ]
Heng, Daniel [13 ,14 ]
Wood, Lori [15 ]
Stacey, Dawn [16 ,17 ]
Kollmannsberger, Christian [18 ,19 ]
Jewett, Michael A. S. [3 ,4 ,5 ]
机构
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Ctr Rehabil & Survivorship Program, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Div Urol, Dept Surg, Toronto, ON, Canada
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Div Urol, Dept Surg Oncol, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
[6] Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada
[7] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[8] James Lind Alliance, Southampton, Hants, England
[9] Univ Alberta, Dept Oncol, Edmonton, AB, Canada
[10] Kidney Canc Res Network Canada, Toronto, ON, Canada
[11] Univ Ottawa, Div Med Oncol, Dept Internal Med, Ottawa, ON, Canada
[12] Mem Univ Newfoundland, Dr H Bliss Murphy Canc Ctr, Dept Med Oncol, St John, NF, Canada
[13] Univ Calgary, Dept Med Oncol, Calgary, AB, Canada
[14] Tom Baker Canc Clin, Calgary, AB, Canada
[15] Dalhousie Univ, Dept Urol, Div Med Oncol, Halifax, NS, Canada
[16] Sch Nursing, Fac Hlth Sci, Ottawa, ON, Canada
[17] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[18] Univ British Columbia, Med Oncol, Vancouver, BC, Canada
[19] Med Oncol BC Canc Agcy, Vancouver, BC, Canada
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2017年 / 11卷 / 12期
基金
加拿大健康研究院;
关键词
RENAL-CELL CARCINOMA; DIAGNOSTIC-ACCURACY; DECISION-MAKING; TUMOR-BIOPSY; MASS BIOPSY; RISK; BIOMARKERS; EVEROLIMUS; IMMUNOTHERAPIES; HETEROGENEITY;
D O I
10.5489/cuaj.4590
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
It is critically important to define disease-specific research priorities to better allocate limited resources. There is growing recognition of the value of involving patients and caregivers, as well as expert clinicians in this process. To our knowledge, this has not been done this way for kidney cancer. Using the transparent and inclusive process established by the James Lind Alliance, the Kidney Cancer Research Network of Canada (KCRNC) sponsored a collaborative consensus-based priority-setting partnership (PSP) to identify research priorities in the management of kidney cancer. The final result was identification of 10 research priorities for kidney cancer, which are discussed in the context of current initiatives and gaps in knowledge. This process provided a systematic and effective way to collaboratively establish research priorities with patients, caregivers, and clinicians, and provides a valuable resource for researchers and funding agencies.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 3 条
  • [1] Setting Research Priorities for Kidney Cancer
    Jones, Jennifer M.
    Bhatt, Jaimin
    Avery, Jonathan
    Laupacis, Andreas
    Cowan, Katherine
    Basappa, Naveen S.
    Basiuk, Joan
    Canil, Christina
    Al-Asaaed, Sohaib
    Heng, Daniel Y. C.
    Wood, Lori
    Stacey, Dawn
    Kollmannsberger, Christian
    Jewett, Michael A. S.
    EUROPEAN UROLOGY, 2017, 72 (06) : 861 - 864
  • [2] Research priorities for pregnancy hypertension: a UK priority setting partnership with the James Lind Alliance
    Ho, Alison
    Webster, Louise
    Bowen, Liza
    Creighton, Fiona
    Findlay, Sarah
    Gale, Chris
    Green, Marcus
    Gronlund, Toto
    Magee, Laura A.
    McManus, Richard J.
    Mistry, Hiten D.
    Singleton, Gemma
    Thornton, Jim
    Whybrow, Rebecca
    Chappell, Lucy
    BMJ OPEN, 2020, 10 (07):
  • [3] Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
    Philpott, Carl M.
    Espehana, Andreas
    Garden, Mairenn
    Ta, Ngan
    Gadi, Nishita
    Kumaresan, Kala
    Maru, Devina
    Stafford, Lorenzo D.
    Bleasdale, Nina
    Boak, Duncan
    CLINICAL OTOLARYNGOLOGY, 2023, 48 (01) : 17 - 24